Eslikarbazepin

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Title in English Eslicarbazepine
Authors

BRÁZDIL Milan

Year of publication 2011
Type Article in Periodical
Magazine / Source Remedia
MU Faculty or unit

Central European Institute of Technology

Citation
Field Neurology, neurosurgery, neurosciences
Keywords eslicarbazepine; epilepsy; add-on therapy
Description Eslicarbazepine acetate (ESL)) is a novel antiepileptic drug that stabilizes the voltage-gated sodium channel. The recommended maintenance dosage after titration is 800-1200 mg given in a single daily dose.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.